MDxHealth SA Ordinary Shares (MDXH) Stock Price

MDXHStock

$0.72−79.17%52W

Market Cap$68.77M

P/E—

PEG Ratio—

Div yield—

Beta0.74

MDXH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-91.63%

Price vs S&P 500 (4W)56.85%

VGM Score57.47

Book Value / Share (Quarterly)$0.12

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)42.79%

Cash Flow / Share (Quarterly)$-0.08

Price vs S&P 500 (YTD)-92.63%

Gross Margin (TTM)64.00%

Net Profit Margin (TTM)-30.98%

EPS (TTM)$-1.00

10-Day Avg Trading Volume1.66M

EPS Excl Extra (TTM)$-1.00

Revenue Growth (5Y)42.34%

EPS (Annual)$-0.67

ROI (Annual)-50.76%

Gross Margin (Annual)64.55%

Net Profit Margin (5Y Avg)-76.80%

Cash / Share (Quarterly)$0.84

Revenue Growth QoQ (YoY)12.74%

ROA (Last FY)-24.25%

Revenue Growth TTM (YoY)18.19%

EBITD / Share (TTM)$-0.33

ROE (5Y Avg)-376.22%

Operating Margin (TTM)-15.07%

Cash Flow / Share (Annual)$-0.42

P/B Ratio3.83x

P/B Ratio (Quarterly)11.78x

Net Income / Employee (Annual)$-107,400

EV / Revenue (TTM)0.53x

Net Interest Coverage (TTM)-0.75x

ROA (TTM)-33.39%

EPS Incl Extra (Annual)$-0.67

Current Ratio (Annual)1.56x

Quick Ratio (Quarterly)1.38x

3-Month Avg Trading Volume4.52M

52-Week Price Return-79.17%

Revenue / Employee (TTM)$521,500

P/S Ratio (Annual)0.21x

Asset Turnover (Annual)0.57x

52-Week High$5.33

Operating Margin (5Y Avg)-60.57%

EPS Excl Extra (Annual)$-0.67

CapEx CAGR (5Y)16.46%

26-Week Price Return-79.70%

Quick Ratio (Annual)1.43x

13-Week Price Return-4.42%

Total Debt / Equity (Annual)4.00x

Current Ratio (Quarterly)1.63x

Enterprise Value$85.59M

Revenue / Share Growth (5Y)-0.54%

Asset Turnover (TTM)1.08x

Revenue / Employee (Annual)$345,800

Inventory Turnover (Annual)10.50x

Pretax Margin (Annual)-32.79%

Cash / Share (Annual)$0.96

3-Month Return Std Dev173.17%

Gross Margin (5Y Avg)57.37%

Net Income / Employee (TTM)$-161,500

ROE (Last FY)-253.79%

Net Interest Coverage (Annual)-0.95x

EPS Basic Excl Extra (Annual)$-0.67

Receivables Turnover (TTM)10.92x

Total Debt / Equity (Quarterly)14.07x

EPS Incl Extra (TTM)$-1.00

Receivables Turnover (Annual)6.85x

ROI (TTM)-48.61%

P/S Ratio (TTM)0.14x

Pretax Margin (5Y Avg)-77.06%

Revenue / Share (Annual)$2.16

Price vs S&P 500 (52W)-97.73%

Year-to-Date Return-79.81%

5-Day Price Return-2.78%

EPS Normalized (Annual)$-0.67

ROA (5Y Avg)-44.62%

Net Profit Margin (Annual)-31.07%

Month-to-Date Return72.42%

EBITD / Share (Annual)$-0.12

Operating Margin (Annual)-13.50%

LT Debt / Equity (Annual)4.93x

ROI (5Y Avg)-81.66%

LT Debt / Equity (Quarterly)12.63x

EPS Basic Excl Extra (TTM)$-1.00

P/B Ratio (Annual)7.82x

Inventory Turnover (TTM)10.95x

Pretax Margin (TTM)-32.12%

Book Value / Share (Annual)$0.31

Price vs S&P 500 (13W)-6.37%

Beta0.74x

Revenue / Share (TTM)$3.12

ROE (TTM)-304.96%

52-Week Low$0.40

vGradeB

gGradeB

mGradeF

vgmGradeC

MDXH Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.19	-$0.18	+7.22%(+$0.01)
Q1 2026	May 13, 2026	-$0.15	-$0.17	-11.84%(-$0.02)
Q4 2025	Feb 26, 2026	-$0.13	-$0.17	-33.33%(-$0.04)
Q3 2025	Nov 12, 2025	-$0.11	-$0.16	-48.15%(-$0.05)
Q2 2025	Aug 14, 2025	-$0.12	-$0.14	-12.90%(-$0.02)

MDXH Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.33

4.17

4.00

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.72
NTRANatera, Inc. Common Stock	F	A	B	$326.26
LHLabcorp Holdings Inc.	C	D	B	$335.11
DGXQuest Diagnostics Inc.	C	D	B	$242.76
GHGuardant Health, Inc. Common Stock	F	A	B	$161.50
CAICaris Life Sciences, Inc. Common Stock	F	A	C	$25.63
RDNTRadNet, Inc. Common Stock	D	C	B	$74.61
BLLNBillionToOne, Inc. Class A Common Stock	F	F	D	$93.24
CELCCelcuity Inc. Common Stock	—	—	C	$88.44
GRALGRAIL, Inc. Common Stock	D	A	B	$80.00
VCYTVeracyte, Inc.	D	A	C	$43.34
CDNACareDx, Inc.	D	B	A	$49.79
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.07
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.81
FRNMFreenome, Inc. Common stock	—	F	A	$14.79
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	C	$11.51
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$33.50
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.61
YDESYD Bio Limited Ordinary Shares	—	—	C	$4.80
BDSXBiodesix, Inc. Common Stock	D	B	A	$26.83
XGNExagen Inc. Common Stock	D	B	C	$7.39
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$10.19
SERASera Prognostics, Inc. Class A Common Stock	D	D	D	$2.07
ADVBAdvanced Biomed Inc. Common Stock	A	—	A	$9.70
AMSAmerican Shared Hospital Services	A	C	D	$1.47
ACONAclarion, Inc. Common Stock	—	B	F	$2.40
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	C	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.42

About MDxHealth SA Ordinary Shares

MDxHealth SA develops molecular diagnostic tests for cancer using proprietary genomic and epigenetic technologies. Its tests help physicians diagnose urologic cancers and predict treatment response and recurrence risk. The company generates revenue through clinical laboratory services and by licensing its DNA methylation platform to partners. It operates in the United States and Europe.